EMA Committee recommends EU label update for Roche Phesgo to allow administration outside of clinical settings Ruchika Sharma4 May 2025 1:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive...
Aurobindo Pharma arm CuraTeQ Biologics gets positive opinion for breast cancer drug Dazublys from EMA Ruchika Sharma26 April 2025 11:30 AM ISTHyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the Committee for...
KATHERINE Final Analysis: Trastuzumab Emtansine Superior to Trastuzumab Post-Neoadjuvant Meghna A Singhania29 Jan 2025 5:56 PM ISTAdjuvant T-DM1 significantly improves long-term invasive disease–free and overall survival versus trastuzumab in residual HER2-positive early breast...
Aurobindo Pharma arm gets positive opinion from EMA Committee for Zefylti for neutropenia treatment Ruchika Sharma14 Dec 2024 12:30 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced that the Committee for...
Submit Clinical Data in Indian Subjects: CDSCO Panel Tells AstraZeneca on Trastuzumab deruxtecan Dr. Divya Colin1 Dec 2024 5:30 PM ISTNew Delhi: Responding to the proposal presented by AstraZeneca Pharma India for the approval of additional indication of the drug Trastuzumab...
Reduce price of 3 anti-cancer drugs: Govt asks manufacturers Ruchika Sharma29 Oct 2024 5:46 PM ISTNew Delhi: To ensure the affordable availability of drugs, the government has asked the companies to reduce the prices of three anti-cancer drugs,...
Zydus Lifesciences gets Mexican marketing approval for Mamitra to treat various cancers \ Ruchika Sharma1 Aug 2024 11:46 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection...
Biocon Biologics, Sandoz Australia ink pact for biosimilars Trastuzumab, Bevacizumab Ruchika Sharma9 Feb 2024 12:30 PM ISTTrastuzumab is a biosimilar of Herceptin and Bevacizumab is a biosimilar of Avastin - both biosimilars are available on the PBS and utilised for the...
Aurobindo Pharma arm bags CDSCO panel recommendation for grant of marketing authorization of biosimilar trastuzumab Ruchika Sharma18 Jan 2024 3:10 PM ISTHyderabad: In a recent BSE filing, Aurobindo Pharma has announced that CuraTeQ Biologics Pvt. Ltd., a wholly owned subsidiary of the...
Sandoz gets EMA Committee positive opinion for breast, gastric cancer biosimilar trastuzumab Ruchika Sharma19 Sept 2023 12:30 PM ISTBasel: Sandoz has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a...
CHMP recommends nod of Merck Keytruda in combo with trastuzumab, chemotherapy to treat HER2-positive advanced GEJ adenocarcinoma expressing PD-L1 Ruchika Sharma24 July 2023 2:30 PM ISTRahway:Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
Breast cancer biosimilar product meets primary endpoint in Phase 3 clinical trial: Aurobindo Pharma Ruchika Sharma5 July 2023 11:30 AM ISTHyderabad:Aurobindo Pharma Limited has announced that the breast cancer biosimilar product, BP02 (Trastuzumab or biosimilar to Herceptin), developed ...
